Febuxotab 40 Tablet contains Febuxostat 40mg, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid in the body, thereby preventing the formation of urate crystals that cause joint inflammation and pain associated with gout attacks. This medication is typically prescribed for long-term management to maintain serum uric acid levels below the target threshold, reducing the frequency and severity of gout flare-ups. Febuxotab 40 is also beneficial for patients who are intolerant to or inadequately managed by other urate-lowering therapies such as allopurinol. It is important to take Febuxotab exactly as prescribed by a healthcare professional, usually once daily, with or without food. Patients should be monitored regularly for serum uric acid levels and kidney and liver function during treatment. Common side effects may include nausea, rash, and joint pain, while serious adverse effects are rare but can include liver abnormalities and cardiovascular events. Febuxotab 40 should be used cautiously in patients with pre-existing liver or heart conditions, and it is not recommended during pregnancy or breastfeeding without medical advice.